Skip to main content
SpringerLink
Log in

Migraine

  • Chapter
  • First Online:
Sensory Nerves

Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 194))

Abstract

Migraine is a neurovascular disorder which affects one fifth of the general population. Disability due to migraine is severe and involves patients from infancy through senescence and it is aggravated by the fact there is no complete cure. However, various drugs for the symptomatic or prophylactic treatment of the disease are available. Recently, better knowledge of the neurobiological and pharmacological aspects of a subset of trigeminal primary sensory neurons has provided key information for the development of effective molecules that specifically target the activation of the trigeminovascular system and may represent a significant advancement in the treatment of the disease. These novel antagonists block the receptor for the sensory neuropeptide calcitonin gene-related peptide (CGRP), which upon release from peripheral terminals of trigeminal perivascular neurons dilates cranial arterial vessels. Whether neurogenic vasodilatation is the major contributing factor to generate the pain and the associated symptoms of the migraine attack or whether other sites of action of CGRP receptor antagonists are responsible for the antimigraine effect of these compounds is the subject of current and intense research.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 429.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 549.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 549.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  • Aiyar N, Daines RA, Disa J et al (2001) Pharmacology of SB-273779, a nonpeptide calcitonin gene-related peptide 1 receptor antagonist. J Pharmacol Exp Ther 296:768–775

    PubMed  CAS  Google Scholar 

  • Alessandri-Haber N, Yeh JJ, Boyd AE et al (2003) Hypotonicity induces TRPV4-mediated nociception in rat. Neuron 39:497–511

    PubMed  CAS  Google Scholar 

  • Amara SG, Arriza JL, Leff SE et al (1985) Expression in brain of a messenger RNA encoding a novel neuropeptide homologous to calcitonin gene-related peptide. Science 229:1094–1097

    PubMed  CAS  Google Scholar 

  • Baluk P, Bertrand C, Geppetti P et al (1995) NK1 receptors mediate leukocyte adhesion in neurogenic inflammation in the rat trachea. Am J Physiol 268:L263–L269

    PubMed  CAS  Google Scholar 

  • Bandell M, Story GM, Hwang SW et al (2004) Noxious cold ion channel TRPA1 is activated by pungent compounds and bradykinin. Neuron 41:849–857

    PubMed  CAS  Google Scholar 

  • Bautista DM, Jordt SE, Nikai T et al (2006) TRPA1 mediates the inflammatory actions of environmental irritants and proalgesic agents. Cell 124:1269–1282

    PubMed  CAS  Google Scholar 

  • Bautista DM, Siemens J, Glazer JM et al (2007) The menthol receptor TRPM8 is the principal detector of environmental cold. Nature 448:204–208

    PubMed  CAS  Google Scholar 

  • Bevan S, Geppetti P (1994) Protons: small stimulants of capsaicin-sensitive sensory nerves. Trends Neurosci 17:509–512

    PubMed  CAS  Google Scholar 

  • Boeglin D, Hamdan FF, Melendez RE et al (2007) Calcitonin gene-related peptide analogues with aza and indolizidinone amino acid residues reveal conformational requirements for antagonist activity at the human calcitonin gene-related peptide 1 receptor. J Med Chem 50:1401–1408

    PubMed  CAS  Google Scholar 

  • Brain SD, Williams TJ (1989) Interactions between the tachykinins and calcitonin gene-related peptide lead to the modulation of oedema formation and blood flow in rat skin. Br J Pharmacol 97:77–82

    PubMed  CAS  Google Scholar 

  • Brain SD, Williams TJ, Tippins JR et al (1985) Calcitonin gene-related peptide is a potent vasodilator. Nature 313:54–56

    PubMed  CAS  Google Scholar 

  • Brazil P, Friedman A (1957) Further observations in craniovascular studies. Neurology 7:52–55

    PubMed  CAS  Google Scholar 

  • Caterina MJ, Schumacher MA, Tominaga M et al (1997) The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 389:816–824

    PubMed  CAS  Google Scholar 

  • Caterina MJ, Rosen TA, Tominaga M et al (1999) A capsaicin-receptor homologue with a high threshold for noxious heat. Nature 398:436–441

    PubMed  CAS  Google Scholar 

  • Chiba T, Yamaguchi A, Yamatani T et al (1989) Calcitonin gene-related peptide receptor antagonist human CGRP-(8–37). Am J Physiol Endocrinol Metab 256:E331–E335

    CAS  Google Scholar 

  • Chuang HH, Prescott ED, Kong H et al (2001) Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2-mediated inhibition. Nature 411:957–962

    PubMed  CAS  Google Scholar 

  • Connor H, Bertin L, Gillies S et al (1998) The GR205171 clinical study group. Clinical evaluation of a novel, potent, CNS penetrating NK1 receptor antagonist in the acute treatment of migraine. Cephalalgia 18:392

    Google Scholar 

  • Cooper GJS, Willis AC, Clark A et al (1987) Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci USA 84:8628–8632

    PubMed  CAS  Google Scholar 

  • Diener HC (2003) RPR100893, a substance-P antagonist, is not effective in the treatment of migraine attacks. Cephalalgia 23:183–185

    PubMed  Google Scholar 

  • Doods H (2001) Development of CGRP antagonists for the treatment of migraine. Curr Opin Investig Drugs 2:1261–1268

    PubMed  CAS  Google Scholar 

  • Doods H, Hallermayer G, Wu D et al (2000) Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist. Br J Pharmacol 129:420–423

    PubMed  CAS  Google Scholar 

  • Doods H, Arndt K, Rudolf K et al (2007) CGRP antagonists: unravelling the role of CGRP in migraine. Trends Pharmacol Sci 28:580–587

    PubMed  CAS  Google Scholar 

  • Durham PL (2004) CGRP-receptor antagonists – a fresh approach to migraine therapy? New Engl J Med 350:1073–1075

    PubMed  CAS  Google Scholar 

  • Edvinsson L (2004) Blockade of CGRP receptors in the intracranial vasculature: a new target in the treatment of headache. Cephalalgia 24:611–622

    PubMed  CAS  Google Scholar 

  • Edvinsson L, Sams A, Jansen-Olesen I et al (2001) Characterisation of the effects of a non-peptide CGRP receptor antagonist in SK-N-MC cells and isolated human cerebral arteries. Eur J Pharmacol 415:39–44

    PubMed  CAS  Google Scholar 

  • Ennis MD, Ghazal NB, Hoffman RL et al (1998) Isochroman-6-carboxamides as highly selective 5-HT1D agonists: potential new treatment for migraine without cardiovascular side effects. J Med Chem 41:2180–2183

    PubMed  CAS  Google Scholar 

  • Fanciullacci M, Tramontana M, Bianco ED et al (1991) Low pH medium induces calcium dependent release of CGRP from sensory nerves of guinea-pig dural venous sinuses. Life Sci 49:PL27–PL30

    PubMed  CAS  Google Scholar 

  • Fanciullacci M, Alessandri M, Figini M et al (1995) Increase in plasma calcitonin gene-related peptide from the extracerebral circulation during nitroglycerin-induced cluster headache attack. Pain 60:119–123

    PubMed  CAS  Google Scholar 

  • Fay T (1935) The mechanism of headache. Trans Am Neurol Assoc 62:74–77

    Google Scholar 

  • Feindel W, Penfield W, Mc NF (1960) The tentorial nerves and localization of intracranial pain in man. Neurology 10:555–563

    PubMed  CAS  Google Scholar 

  • Fernandez-Patron C, Stewart KG, Zhang Y et al (2000) Vascular matrix metalloproteinase-2-dependent cleavage of calcitonin gene-related peptide promotes vasoconstriction. Circ Res 87:670–676

    PubMed  CAS  Google Scholar 

  • Ferrari MD, Saxena PR (1993) On serotonin and migraine: a clinical and pharmacological review. Cephalalgia 13:151–165

    PubMed  CAS  Google Scholar 

  • Ferrari MD, Roon KI, Lipton RB et al (2001) Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet 358:1668–1675

    PubMed  CAS  Google Scholar 

  • Fluhmann B, Muff R, Hunziker W et al (1995) A human orphan calcitonin receptor-like structure. Biochem Biophys Res Commun 206:341–347

    PubMed  CAS  Google Scholar 

  • Franco-Cereceda A (1991) Calcitonin gene-related peptide and human epicardial coronary arteries: presence, release and vasodilator effects. Br J Pharmacol 102:506–510

    PubMed  CAS  Google Scholar 

  • Gazzieri D, Trevisani M, Springer J et al (2007) Substance P released by TRPV1-expressing neurons produces reactive oxygen species that mediate ethanol-induced gastric injury. Free Radic Biol Med. 43:581–589

    PubMed  CAS  Google Scholar 

  • Geppetti P, Holzer P (1996) Neurogenic inflammation. CRC, Boca Raton

    Google Scholar 

  • Geppetti P, Del Bianco E, Cecconi R et al (1992) Capsaicin releases calcitonin gene-related peptide from the human iris and ciliary body in vitro. Regul Pept 41:83–92

    PubMed  CAS  Google Scholar 

  • Giffin NJ, Kowacs F, Libri V et al (2003) Effect of the adenosine A1 receptor agonist GR79236 on trigeminal nociception with blink reflex recordings in healthy human subjects. Cephalalgia 23:287–292

    PubMed  CAS  Google Scholar 

  • Goadsby PJ, Edvinsson L, Ekman R (1990) Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 28:183–187

    PubMed  CAS  Google Scholar 

  • Goadsby PJ, Lipton RB, Ferrari MD (2002a) Migraine – current understanding and treatment. New Engl J Med 346:257–270

    PubMed  CAS  Google Scholar 

  • Goadsby PJ, Hoskin KL, Storer RJ et al (2002b) Adenosine A1 receptor agonists inhibit trigeminovascular nociceptive transmission. Brain 125:1392–1401

    PubMed  CAS  Google Scholar 

  • Goldstein DJ, Wang O, Saper JR et al (1997) Ineffectiveness of neurokinin-1 antagonist in acute migraine: a crossover study. Cephalalgia 17:785–790

    PubMed  CAS  Google Scholar 

  • Goldstein J, Roon I, Offen W et al (1999) Migraine treatment with selective with 5-ht1F receptor agonist (SSOFRA) LY334370. Cephalalgia 19:318

    Google Scholar 

  • Gomez-Mancilla B, Cutler N, Leibowitz M et al (2001) Safety and efficacy of PNU-142633, a selective 5-HT1D agonist, in patients with acute migraine. Cephalalgia 21:727–732

    PubMed  CAS  Google Scholar 

  • Graham J, Wolff H (1938) Mechanism of migraine headache and action of ergotamine tartrate. Arch Neurol Psychiatry 39:737–763

    CAS  Google Scholar 

  • Gray DW, Marshall I (1992) Human alpha-calcitonin gene-related peptide stimulates adenylate cyclase and guanylate cyclase and relaxes rat thoracic aorta by releasing nitric oxide. Br J Pharmacol 107:691–696

    PubMed  CAS  Google Scholar 

  • Ho TW, Mannix LK, Fan X et al (2007) Randomized controlled trial of an oral CGRP antagonist, MK-0974, in acute treatment of migraine. Neurology 70:1304–1312

    PubMed  Google Scholar 

  • Huang SM, Bisogno T, Trevisani M et al (2002) An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. Proc Natl Acad Sci USA 99:8400–8405

    PubMed  CAS  Google Scholar 

  • Humphrey PP, Bland-Ward PA, Carruthers AM et al (2001) Inhibition of trigemnial nociceptive afferents by adenosine A1 receptor activation: a novel approach towards the design of new anti-migraine compounds. Cephalalgia 21:268–269

    Google Scholar 

  • Hwang SW, Cho H, Kwak J et al (2000) Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances. Proc Natl Acad Sci USA 97:6155–6156

    PubMed  CAS  Google Scholar 

  • Jordt SE, Bautista DM, Chuang HH et al (2004) Mustard oils and cannabinoids excite sensory nerve fibres through the TRP channel ANKTM1. Nature 427:260–265

    PubMed  CAS  Google Scholar 

  • Juhasz G, Zsombok T, Modos EA et al (2003) NO-induced migraine attack: strong increase in plasma calcitonin gene-related peptide (CGRP) concentration and negative correlation with platelet serotonin release. Pain 106:461–470

    PubMed  CAS  Google Scholar 

  • Kapoor K, Arulmani U, Heiligers JPC et al (2003) Effects of the CGRP receptor antagonist BIBN4096BS on capsaicin-induced carotid haemodynamic changes in anaesthetised pigs. Br J Pharmacol 140:329–338

    PubMed  CAS  Google Scholar 

  • Kitamura K, Kangawa K, Kawamoto M et al (1993) Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 192:553–560

    PubMed  CAS  Google Scholar 

  • Knotkova H, Pappagallo M, Szallasi A (2008) Capsaicin (TRPV1 Agonist) therapy for pain relief: farewell or revival? Clin J Pain 24:142–154

    PubMed  Google Scholar 

  • Lance J (1969) Mechanism and management of headache. Butterworths, New York

    Google Scholar 

  • Lassen LH, Haderslev PA, Jacobsen VB et al (2002) CGRP may play a causative role in migraine. Cephalalgia 22:54–61

    PubMed  CAS  Google Scholar 

  • Lennerz JK, Ruhle V, Ceppa EP et al (2008) Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: differences between peripheral and central CGRP receptor distribution. J Comp Neurol 507:1277–1299

    PubMed  CAS  Google Scholar 

  • Lewis T (1937) The nocifensor system of nerves and its reactions. Br Med J 194:431–435

    Google Scholar 

  • Liedtke W, Choe Y, Marti-Renom MA et al (2000) Vanilloid receptor-related osmotically activated channel (VR-OAC), a candidate vertebrate osmoreceptor. Cell 103:525–535

    PubMed  CAS  Google Scholar 

  • Macpherson LJ, Geierstanger BH, Viswanath V et al (2005) The pungency of garlic: activation of TRPA1 and TRPV1 in response to allicin. Curr Biol 15:929–934

    PubMed  CAS  Google Scholar 

  • Markowitz S, Saito K, Moskowitz MA (1987) Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain. J Neurosci 7:4129–4136

    PubMed  CAS  Google Scholar 

  • McKemy DD, Neuhausser WM, Julius D (2002) Identification of a cold receptor reveals a general role for TRP channels in thermosensation. Nature 416:52–58

    PubMed  CAS  Google Scholar 

  • McLatchie LM, Fraser NJ, Main MJ et al (1998) RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 393:333–339

    PubMed  CAS  Google Scholar 

  • Morris HR, Panico M, Etienne T et al (1984) Isolation and characterization of human calcitonin gene-related peptide. Nature 308:746–748

    PubMed  CAS  Google Scholar 

  • Moskowitz MA, Buzzi MG (1991) Neuroeffector functions of sensory fibres: implications for headache mechanisms and drug actions. J Neurol 238:S18–S22

    PubMed  Google Scholar 

  • Mudderry PK, Ghatei MA, Spokes RA et al (1988) Differential expression of [alpha]-CGRP and [beta]-CGRP by primary sensory neurons and enteric autonomic neurons of the rat. Neuroscience 25:195–205

    Google Scholar 

  • Nagata K, Duggan A, Kumar G et al (2005) Nociceptor and hair cell transducer properties of TRPA1, a channel for pain and hearing. J Neurosci 25:4052–4061

    PubMed  CAS  Google Scholar 

  • Nicoletti P, Trevisani M, Manconi M et al (2008) Ethanol causes neurogenic vasodilation by TRPV1 activation and CGRP release in the trigeminovascular system of the guinea pig. Cephalalgia 28:9–17

    PubMed  CAS  Google Scholar 

  • Nilius B, Owsianik G, Voets T et al (2007) Transient receptor potential cation channels in disease. Physiol Rev 87:165–217

    PubMed  CAS  Google Scholar 

  • Njuki F, Nicholl CG, Howard A et al (1993) A new calcitonin-receptor-like sequence in rat pulmonary blood vessels. Clin Sci (Lond) 85:385–388

    CAS  Google Scholar 

  • Olesen J, Diener HC, Husstedt IW et al (2004) Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med 350:1104–1110

    PubMed  CAS  Google Scholar 

  • Paone DV, Shaw AW, Nguyen DN et al (2007) Potent, orally bioavailable calcitonin gene-related peptide receptor antagonists for the treatment of migraine: discovery of N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide (MK-0974). J Med Chem 50:5564–5567

    PubMed  CAS  Google Scholar 

  • Peier AM, Moqrich A, Hergarden AC et al (2002) A TRP channel that senses cold stimuli and menthol. Cell 108:705–715

    PubMed  CAS  Google Scholar 

  • Penfield W, McNaughton M (1940) Dural headache and the innervation of the dura mater. Arch Neurol Psychiatr 44:43–75

    Google Scholar 

  • Petermann J, Born W, Chang J et al (1987) Identification in the human central nervous system, pituitary, and thyroid of a novel calcitonin gene-related peptide, and partial amino acid sequence in the spinal cord. J Biol Chem 262:542–545

    PubMed  CAS  Google Scholar 

  • Petersen K, Birk S, Lassen L et al (2005) The CGRP-antagonist, BIBN4096BS does not affect cerebral or systemic haemodynamics in healthy volunteers. Cephalalgia 25:139–147

    PubMed  CAS  Google Scholar 

  • Premkumar LS, Ahern GP (2000) Induction of vanilloid receptor channel activity by protein kinase C. Nature 408:985–990

    PubMed  CAS  Google Scholar 

  • Quirion R, D Van Rossum, Dumont Y et al (1992) Characterization of CGRP1 and CGRP2 receptor subtypes. Ann N Y Acad Sci 657:88–105

    PubMed  CAS  Google Scholar 

  • Raddino R, Pela G, Manca C et al (1997) Mechanism of action of human calcitonin gene-related peptide in rabbit heart and in human mammary arteries. J Cardiovasc Pharmacol 29:463–470

    PubMed  CAS  Google Scholar 

  • Ramadan NM, Skljarevski V, Phebus LA et al (2003) 5-HT1F receptor agonists in acute migraine treatment: a hypothesis. Cephalalgia 23:776–785

    PubMed  CAS  Google Scholar 

  • Ray B, Wolff H (1940) Experimental studies on headache: pain-sensitive structures of the head and their significance in headache. Arch Surg 41:813–856

    Google Scholar 

  • Salvatore CA, Hershey JC, Corcoran HA et al (2008) Pharmacological characterization of MK-0974 [N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carbox amide], a potent and orally active calcitonin gene-related peptide receptor antagonist for the treatment of migraine. J Pharmacol Exp Ther 324:416–421

    PubMed  CAS  Google Scholar 

  • Schoonman GG, van der Grond J, Kortmann C et al (2008) Migraine headache is not associated with cerebral or meningeal vasodilatation – a 3T magnetic resonance angiography study. Brain 131:2192–2200

    PubMed  CAS  Google Scholar 

  • Simone DA, Ochoa J (1991) Early and late effects of prolonged topical capsaicin on cutaneous sensibility and neurogenic vasodilatation in humans. Pain 47:285–294

    PubMed  CAS  Google Scholar 

  • Smith D, Hill RG, Edvinsson L et al (2002) An immunocytochemical investigation of human trigeminal nucleus caudalis: CGRP, substance P and 5-HT1D-receptor immunoreactivities are expressed by trigeminal sensory fibres. Cephalalgia 22:424–431

    PubMed  CAS  Google Scholar 

  • Snider RM, Constantine JW, Lowe JA 3rd et al (1991) A potent nonpeptide antagonist of the substance P (NK1) receptor. Science 251:435–437

    PubMed  CAS  Google Scholar 

  • Story GM, Peier AM, Reeve AJ et al (2003) ANKTM1, a TRP-like channel expressed in nociceptive neurons, is activated by cold temperatures. Cell 112:819–829

    PubMed  CAS  Google Scholar 

  • Struthers AD, Brown MJ, Macdonald DW et al (1986) Human calcitonin gene related peptide: a potent endogenous vasodilator in man. Clin Sci (Lond) 70:389–393

    CAS  Google Scholar 

  • Szallasi A, Blumberg PM (1999) Vanilloid (capsaicin) receptors and mechanisms. Pharmacol Rev 51:159–212

    PubMed  CAS  Google Scholar 

  • Szolcsanyi J (1977) A pharmacological approach to elucidation of the role of different nerve fibres and receptor endings in mediation of pain. J Physiol 73:251–259

    CAS  Google Scholar 

  • Taylor CK, Smith DD, Hulce M et al (2006) Pharmacological characterization of novel alpha-calcitonin gene-related peptide (CGRP) receptor peptide antagonists that are selective for human CGRP receptors. J Pharmacol Exp Ther 319:749–757

    PubMed  CAS  Google Scholar 

  • Tfelt-Hansen P, De Vries P, Saxena PR (2000) Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy. Drugs 60:1259–1287

    PubMed  CAS  Google Scholar 

  • Thomsen LL, Iversen HK, Brinck TA et al (1993) Arterial supersensitivity to nitric oxide (nitroglycerin) in migraine sufferers. Cephalalgia 13:395–399

    PubMed  CAS  Google Scholar 

  • Tominaga M, Caterina MJ, Malmberg AB et al (1998) The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron 21:531–543

    PubMed  CAS  Google Scholar 

  • Trevisani M, Smart D, Gunthorpe MJ et al (2002) Ethanol elicits and potentiates nociceptor responses via the vanilloid receptor-1. Nat Neurosci 5:546–551

    PubMed  CAS  Google Scholar 

  • Welch KMA (2003) Concepts of migraine headache pathogenesis: insights into mechanisms of chronicity and new drug targets. Neurol Sci 24:S149–S153

    PubMed  Google Scholar 

  • Williamson DJ, Hill RG, Shepheard SL et al (2001) The anti-migraine 5-HT(1B/1D) agonist rizatriptan inhibits neurogenic dural vasodilation in anaesthetized guinea-pigs. Br J Pharmacol 133:1029–1034

    PubMed  CAS  Google Scholar 

  • Wolff H (1948) Headache and other head pain. Oxford University Press, New York, pp 59–97

    Google Scholar 

  • Zygmunt PM, Petersson J, Andersson DA et al (1999) Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 400:452–457

    PubMed  CAS  Google Scholar 

Download references

Acknowledgements

The paper was supported in part by grants from Consorzio Ferrara Ricerche, Ferrara, and by Fondazione DEI-Onlus, Florence, Italy.

Author information

Authors and Affiliations

  1. Centre for the Study of Headache and Department of Preclinical and Clinical Pharmacology, University of Florence, Florence, Italy

    Silvia Benemei, Paola Nicoletti, Jay G. Capone & Francesco De Cesaris

  2. Headache Center, University Hospital S. Anna, Ferrara, Italy

    Pierangelo Geppetti

Authors
  1. Silvia Benemei
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paola Nicoletti
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jay G. Capone
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Francesco De Cesaris
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Pierangelo Geppetti
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Dept. Medicine, Johns Hopkins Asthma & Allergy Center, Hopkins Bayview Circle 5501, Baltimore, 21224, U.S.A.

    Brendan J. Canning

  2. School of Biomedical & Health Sciences, King's College London, Guy's Campus, London, SE1 9RT, United Kingdom

    Domenico Spina

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Benemei, S., Nicoletti, P., Capone, J.G., Cesaris, F.D., Geppetti, P. (2009). Migraine. In: Canning, B., Spina, D. (eds) Sensory Nerves. Handbook of Experimental Pharmacology, vol 194. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-79090-7_3

Download citation

Publish with us

Policies and ethics

Search

Navigation